SLC9A6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.621200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.845800E-01
Normal-vs-Stage2
6.758000E-01
Normal-vs-Stage3
1.181590E-01
Normal-vs-Stage4
4.618400E-01
Stage1-vs-Stage2
5.411000E-01
Stage1-vs-Stage3
4.414400E-02
Stage1-vs-Stage4
3.239600E-01
Stage2-vs-Stage3
1.694830E-01
Stage2-vs-Stage4
1.315810E-01
Stage3-vs-Stage4
4.359700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.484200E-01
Normal-vs-AfricanAmerican
9.635200E-01
Normal-vs-Asian
6.029800E-01
Caucasian-vs-AfricanAmerican
7.098000E-01
Caucasian-vs-Asian
5.953000E-01
AfricanAmerican-vs-Asian
5.579400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.545400E-01
Normal-vs-Female
7.809000E-01
Male-vs-Female
8.352000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.958200E-01
Normal-vs-Age(41-60Yrs)
7.513600E-01
Normal-vs-Age(61-80Yrs)
5.602200E-01
Normal-vs-Age(81-100Yrs)
1.015180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.476000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.627800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.125600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.722080E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.205200E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.464800E-01
Normal-vs-Daily Drinker
7.242600E-01
Normal-vs-Weekly Drinker
5.371800E-01
Normal-vs-Occasional Drinker
7.687400E-01
Normal-vs-Social Drinker
9.204400E-01
Non Drinker-vs-Daily Drinker
5.055400E-01
Non Drinker-vs-Weekly Drinker
6.130400E-01
Non Drinker-vs-Occasional Drinker
2.094000E-02
Non Drinker-vs-Social Drinker
1.503420E-01
Daily Drinker-vs-Weekly Drinker
8.593400E-01
Daily Drinker-vs-Occasional Drinker
2.272800E-01
Daily Drinker-vs-Social Drinker
4.228800E-01
Weekly Drinker-vs-Occasional Drinker
1.437580E-01
Weekly Drinker-vs-Social Drinker
3.252000E-01
Occasional Drinker-vs-Social Drinker
7.873000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.557160E-01
Normal-vs-Grade 2
1.730170E-02
Normal-vs-Grade 3
1.871900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.156200E-01
Grade 1-vs-Grade 3
6.124400E-01
Grade 1-vs-Grade 4
1.557160E-01
Grade 2-vs-Grade 3
7.573000E-01
Grade 2-vs-Grade 4
1.730170E-02
Grade 3-vs-Grade 4
1.871900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.741800E-01
Normal-vs-NonDiabetic
8.011600E-01
Diabetic-vs-NonDiabetic
1.967820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.653200E-01
Normal-vs-NoPancreatitis
6.893600E-01
Pancreatitis-vs-NoPancreatitis
9.225200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.887200E-01
Normal-vs-N1
6.895000E-01
N0-vs-N1
4.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.055000E-01
Normal-vs-TP53-NonMutant
9.695200E-01
TP53-Mutant-vs-TP53-NonMutant
8.591000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
